Saturday 17 October 2026
Export COO’s income statement to Excel — free account
The Cooper Companies, Inc.
COO Healthcare Medical Instruments & Supplies
The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
57.94
0.54
+0.94%
Follow COO
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
37.19 | 39.93 | 53.31 | 24.68 |
P/S ratio |
3.40 | 3.80 | 2.90 | 3.29 | |
P/FCF ratio |
32.09 | 32.15 | 21.54 | 20.59 | |
P/Operating CF |
56.15 | 60.53 | 67.10 | 40.85 | |
P/B ratio |
1.69 | 1.89 | 1.49 | 1.68 | |
Price to Tangible BV |
4.97 | 5.41 | 4.29 | 4.64 | |
EV/Sales |
3.99 | 4.38 | 3.45 | 3.86 | |
EV/EBITDA |
15.39 | 16.58 | 16.53 | 17.61 | |
EV/Operating CF |
20.49 | 20.97 | 15.31 | 15.82 | |
EV/FCF |
37.62 | 36.98 | 25.61 | 24.11 | |
Quick Ratio |
0.84 | 0.58 | 0.53 | 0.51 | |
Current Ratio |
1.89 | 1.34 | 1.27 | 1.22 | |
Net Debt/EBITDA |
10.03 | 7.70 | 36.05 | 7.55 | |
Debt/Assets |
20.21% | 20.12% | 19.71% | 20.08% | |
Debt/Equity |
0.30 | 0.30 | 0.30 | 0.31 | |
Asset Turnover |
0.33 | 0.34 | 0.34 | 0.34 | |
Operating CF/Net income |
2.93 | 1.99 | (2.35) | 0.79 | |
Capex/Depreciation |
(1.00) | (1.07) | (0.91) | (0.73) | |
Interest Coverage |
5.75 | 9.50 | (1.48) | 10.33 | |
Research and Development Expense of Revenue |
3.89% | 4.33% | 3.93% | 3.90% | |
Selling, General and Administrative Expense of Revenue |
39.36% | 38.10% | 62.52% | 37.64% | |
Intangible Assets out of Total Assets |
0.44 | 0.44 | 0.43 | 0.42 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.15) | (0.12) | (0.16) | (0.15) | |
Graham Number |
41.84 | 44.06 | 33.49 | 53.34 | |
Earnings Yield |
2.69% | 2.50% | 1.88% | 4.05% | |
Free Cash Flow Yield |
3.12% | 3.11% | 4.64% | 4.86% | |
Revenue per Share |
5.35 | 5.23 | 5.55 | 5.52 | |
Operating CF per Share |
1.25 | 1.33 | 0.94 | 1.77 | |
Capex per Share |
(0.49) | (0.52) | (0.44) | (0.36) | |
Free Cash Flow per Share |
0.75 | 0.81 | 0.49 | 1.41 | |
Cash per Share |
0.56 | 0.64 | 0.71 | 0.80 | |
Shareholders Equity per Share |
41.38 | 42.72 | 42.25 | 43.15 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
41.38 | 42.72 | 42.25 | 43.15 | |
Free Cash Flow |
149.90 | 158.70 | 96.40 | 273.00 | |
Working Capital |
993.60 | 538.10 | 495.10 | 414.90 | |
Capital Expenditures |
(98.00) | (102.20) | (86.40) | (68.70) | |
Net Current Asset Value |
(2,049.30) | (1,926.40) | (1,943.40) | (2,063.50) | |
EV/EBIT |
23.89 | 25.45 | 29.30 | 30.04 | |
Capex to Sales |
0.09 | 0.10 | 0.08 | 0.06 | |
Price to Operating Income |
20.38 | 22.13 | 24.63 | 25.65 | |
| Other line items | |||||
Average Receivables |
773.00 | 761.75 | 795.05 | 790.60 | |
Average Payables |
280.45 | 213.65 | 238.75 | 253.55 | |
Average Inventory |
824.35 | 859.65 | 888.35 | 896.25 | |
Average Assets |
12,355.00 | 12,323.20 | 12,447.95 | 12,525.05 | |
Average Common Equity |
8,161.35 | 8,245.75 | 8,263.60 | 8,340.70 |
Columns are period end dates